The effect of levetiracetam on depression and anti-oxidant activity in patients with epilepsy

Background: Levetiracetam (LEV) is approved for treating epilepsy. The current evidence shows that LEV can cause behavioral problems such as depression. It is well-known that depression is associated with oxidative stress. Therefore, we conducted this study to assess the influence of LEV on depressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehvari-Habibabadi, Jafar, Zare, Mohammad, Aghaye-Ghazvini, Mohammad Reza, Rahnama, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189196/
https://www.ncbi.nlm.nih.gov/pubmed/38011345
http://dx.doi.org/10.18502/cjn.v21i4.11719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189196/
https://www.ncbi.nlm.nih.gov/pubmed/38011345
http://dx.doi.org/10.18502/cjn.v21i4.11719

Ejemplares similares